A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
AstraZeneca
National Cancer Institute (NCI)
The New York Proton Center
Association Francaise pour la Recherche Thermale
University Health Network, Toronto
Jazz Pharmaceuticals
Alliance for Clinical Trials in Oncology
Fate Therapeutics
DualityBio Inc.
Eastern Cooperative Oncology Group
The Second Affiliated Hospital of Hainan Medical University
EMD Serono
Terremoto Biosciences Inc.
Stanford University
Ensem Therapeutics
Varian, a Siemens Healthineers Company
PMV Pharmaceuticals, Inc
UMC Utrecht
University of Chicago
University of California, Irvine
Eli Lilly and Company
ViroMissile, Inc.
University Health Network, Toronto
Washington University School of Medicine
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
IDEAYA Biosciences
Baylor College of Medicine
University of Colorado, Denver
MacroGenics
Avacta Life Sciences Ltd
SystImmune Inc.
Daiichi Sankyo
University of Nebraska
Oscotec Inc.
Kidney Cancer Research Bureau
Adela, Inc
Natera, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
The Netherlands Cancer Institute
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
Tanabe Pharma America, Inc.
XEOS Medical
University Health Network, Toronto
MediLink Therapeutics (Suzhou) Co., Ltd.
Rutgers, The State University of New Jersey
Massive Bio, Inc.
LigaChem Biosciences, Inc.